Kairos Pharma Ltd. has announced a change in its certifying accountants as part of its recent financial reporting update. On April 23, 2025, the company's audit committee appointed Weinberg and Company, P.A. as its new independent registered public accounting firm for the fiscal year ending December 31, 2025. This decision resulted in the dismissal of Marcum LLP, effective on the same date. Marcum's audit reports for the years ended December 31, 2024, and 2023 included no adverse opinions or disclaimers, although the 2023 report noted uncertainty regarding the company's ability to continue as a going concern. There were no disagreements or reportable events with Marcum regarding accounting principles or practices. This transition follows the identification of material weaknesses in internal controls over financial reporting for the fiscal years 2024 and 2023.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。